Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - MarketLine Financial Deals

Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - MarketLine Financial Deals
Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Published Nov 10, 2016
56 pages — Published Nov 10, 2016
Price US$ 350.00  |  Buy this Report Now

About This Report

  
Abstract:

Project Synopsis:

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

Marketlines' Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) since January 2007.

Scope:

- Provides intelligence on Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.)'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) and its subsidiaries since 2007.
- Information about key financial and legal advisors for Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.)'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Highlights:

This report includes Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.)'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.). These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Purchase:

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.)'s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors' business structure and growth strategies.

  
Source:
Document ID
B282D1F5-2850-4D03-99C3-3510034572ED
Industry
Ticker
BOTA.OQ=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
TABLE OF CONTENTS
COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
--Mergers and Acquisitions - Overview
--Mergers and Acquisitions - Deal reports
--Partnership - Deal reports
CAPITAL RAISING
--Capital Raising - Overview
--Capital Raising - Deal reports
DIVESTMENTS
--Divestments - Overview
--Divestments - Deal reports
--Private Equity and Ownership - Deal reports
APPENDIX
--About Datamonitor Financial Deals Database
--Deal Definition and Methodology
--About Datamonitor
--Datamonitor Professional Services Knowledge Center
LIST OF TABLES
--Biota Pharmaceuticals activity by deal type - volume (trailing twelve months (TTM))
--Biota Pharmaceuticals M&A activity by geography (2012 -YTD2016)
--Biota Pharmaceuticals activity by deal type - volume (2012 -YTD2016)
--Biota Pharmaceuticals M&A average deal size - value ($m) (2012 -YTD2016)
--Biota Pharmaceuticals legal advisor ranking by value ($m)
--Biota Pharmaceuticals financial advisor ranking by value ($m)
--Top Deals(2012 -YTD2016)
--Biota Pharmaceuticals targets and partners (2012 -YTD2016)
--Biota Pharmaceuticals M&A volume and value trend (2012-YTD2016)
--Biota Pharmaceuticals M&A activity by geography (2012-YTD2016)
--Biota Pharmaceuticals capital raising volume and value trend (2012-YTD2016)
--Biota Pharmaceuticals capital raising by deal type (2012-YTD2016)
--Biota Pharmaceuticals divestments volume and value trend (2012-YTD2016)
--Biota Pharmaceuticals divestments activity by geography (2012-YTD2016)
LIST OF FIGURES
--Biota Pharmaceuticals activity by deal type - volume (trailing twelve months (TTM))
--Biota Pharmaceuticals M&A activity by geography (2012-YTD2016)
--Biota Pharmaceuticals activity by deal type - volume (2012-YTD2016)
--Biota Pharmaceuticals M&A average deal size - value ($m)
--Biota Pharmaceuticals M&A volume and value trend (2012-YTD2016)
--Biota Pharmaceuticals M&A activity by geography (2012-YTD2016)
--Biota Pharmaceuticals capital raising volume and value trend (2012-YTD2016)
--Biota Pharmaceuticals capital raising by deal type (2012-YTD2016)
--Biota Pharmaceuticals divestments volume and value trend (2012-YTD2016)

Table Of Contents

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report" Nov 10, 2016. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Biota-Pharmaceuticals-Inc-formerly-Nabi-Biopharmaceuticals-Inc-Mergers-Acquisitions-M-A-Partnerships-Alliances-and-Investment-Report-2052-53608>
  
APA:
MarketLine Financial Deals. (2016). Biota Pharmaceuticals, Inc. (formerly Nabi Biopharmaceuticals, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Nov 10, 2016. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Biota-Pharmaceuticals-Inc-formerly-Nabi-Biopharmaceuticals-Inc-Mergers-Acquisitions-M-A-Partnerships-Alliances-and-Investment-Report-2052-53608>
  
US$ 350.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.